ARHGAP35 and melanoma: Overall, we provide evidence that a combined treatment approach consisting of suppressed p190RhoGAP expression into tumours and inactivation of p110δ PI3K in macrophages blocks melanoma and SCC progression by decreasing ATX expression levels.